Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C-Reference-Cited by-同舟云学术

Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C

Published:2014-07-29 Issue:3 Volume:60 Page:832-843
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Tsochatzis Emmanuel A.¹^ORCID,Crossan Catriona²,Longworth Louise²,Gurusamy Kurinchi³,Rodriguez-Peralvarez Manolo¹,Mantzoukis Konstantinos¹,O'Brien Julia¹,Thalassinos Evangelos¹,Papastergiou Vassilios¹,Noel-Storr Anna⁴,Davidson Brian³,Burroughs Andrew K.¹

Affiliation:

1. Sheila Sherlock Liver Unit and UCL Institute for Liver and Digestive Health, Royal Free Hospital; London UK

2. Health Economics Research Group; Brunel University; Uxbridge UK

3. Royal Free Campus; UCL Medical School; London UK

4. Cochrane Dementia and Cognitive Improvement Group; Nuffield Department of Medicine, Oxford University; Oxford UK

Funder

Health Technology Assessment programme

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.27296/fullpdf

Reference31 articles.

1. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups;Poynard;Lancet,1997

2. EASL Clinical Practice Guidelines: management of hepatitis C virus infection;European Association for the Study of the Liver;J Hepatol,2011

3. Clinical decisions. Management of incidental hepatitis C virus infection;Afdhal;N Engl J Med,2009

4. Noninvasive assessment of liver fibrosis;Martinez;Hepatology,2011

5. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies;Whiting;Ann Intern Med,2011

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarcadores séricos para la evaluación de la fibrosis hepática;Advances in Laboratory Medicine / Avances en Medicina de Laboratorio;2024-02-14

2. Serum biomarkers for liver fibrosis assessment;Advances in Laboratory Medicine / Avances en Medicina de Laboratorio;2023-11-14

3. Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease Specialists for the Diagnosis and Treatment of Chronic Hepatitis C;Russian Journal of Gastroenterology, Hepatology, Coloproctology;2023-06-04

4. A novel mechanistic approach for the anti-fibrotic potential of rupatadine in rat liver via amendment of PAF/NF-ĸB p65/TGF-β1 and hedgehog/HIF-1α/VEGF trajectories;Inflammopharmacology;2023-02-22

5. Predictive risk markers in alcoholism;Advances In Clinical Chemistry;2023